Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing Type
4
Filing Date
10/1/2020
Updated
10/2/20, 7:51 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership